Approval · Notice of Compliance 20079 · 2017
BACKUP PLAN: Notice of Compliance 20079
Issued November 22, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20079
- Date
- November 22, 2017
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph
- Canadian reference product
- PLAN B (Paladin Labs Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BACKUP PLAN | Not yet assigned | — |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB